Guest Column

Abortionists push online access to abortion pills amid coronavirus panic

abortion pill

(MRC-TV) Amid mass panic over the seemingly inevitable coronavirus outbreak sweeping the country, some in the abortion industry are using the widespread alarm to tout the importance of…abortion.

Why? Well, that’s unclear, given that abortion has nothing at all to do with the coronavirus. Even still, several abortionists and abortion advocates have taken to Twitter to stump for the public’s “right” to access abortion pills via telemedicine (i.e., an online consultation without having to physically see a doctor).

Dr. Dustin Costescu, an OBGYN, associate professor and “sexual medicine specialist” at McMaster University, tweeted that “self-managed abortion is safe” and “avoids in person appointments,” inexplicably predicting that telemedicine abortion “will be necessary to address the increased incidence of unintended pregnancies that will result from self-quarantine.”

After claiming that at-home abortions via the abortion pill are “safe,” Costescu seemingly contradicted himself by adding that “Systems need to be prepared to respond to possible complications from failed self-management, including ectopic pregnancy and bleeding.”

“But,” he simultaneously said, “abortion by telemedicine or self management are safe and effective strategies to reduce visits during the outbreak.”

Dr. Daniel Grossman, another vocal abortionist with a large Twitter following, retweeted Costescu’s statements, adding that the coronavirus is “a reminder of why we must expand telemedicine to patients, including for medication abortion.”

“Patients should have access to healthcare, whether they are able to make it to the clinic or not,” he wrote. “Self-managed abortion and telemedicine can ensure they receive care.”

READ: If the abortion industry has its way, abortion will no longer be ‘between a woman and her doctor’

The big push for online abortion pills prescribed via telemedicine comes just after the Ohio state Senate passed a bill that would outlaw telemedicine abortions within the state, requiring instead that physicians be certified to distribute the drugs, as well as mandating that an in-person evaluation be conducted before a patient is prescribed the abortion medication.

The drug centers on two drugs. Mifepristone, or “Mifeprex,” is a synthetic steroid. When taken in conjunction with misoprostol, the combination carries a 95 percent success rate of forcing a woman’s body to miscarry. Because of its function, it’s recommended that the drug only be taken up until the 10th week of pregnancy. The roughly five percent of children who survive the process are at much greater risk of birth defects.

While abortion supporters say the medication carries a low risk of complications, the FDA warns against women with certain conditions taking these drugs, as side effects can include uncontrolled bleeding that requires surgery, sepsis, flu-like symptoms and even death. The FDA added it has “received reports of serious adverse events in women who took Mifeprex, including “one case of ectopic pregnancy resulting in death; several cases of severe systemic infection (also called sepsis), including some that were fatal; and a single case of non-fatal heart attack.”

Editor’s Note: This article was published at MRC-TV and is reprinted here with permission.

“Like” Live Action News on Facebook for more pro-life news and commentary!

What is Live Action News?

Live Action News is pro-life news and commentary from a pro-life perspective. Learn More

Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.

GUEST ARTICLES: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated. (See here for Open License Agreement.) Thank you for your interest in Live Action News!



To Top